Thus, this study provides a rationale for the application of multimodal immunotherapeutic regimens composed of adenovirus-based vaccine (Ad-CEA or Ad-Twist), N-803, OX40, 4-1BB, PD-L1, and docetaxel for both warm and cool tumors for a successful anti-tumor immune response. Here, TNFRSF9 is linked to neoplasm.